Proteasome Augmentation Mitigates Age-Related Cognitive Decline in Mice

Area of Science:

• Neuroscience
• Molecular Biology
• Aging Research

Background:

• The aging brain shows reduced proteasome function, impacting neuronal plasticity and memory.
• Proteasome inhibitors are known to impair cognitive processes.
• The precise mechanisms behind age-related proteasome dysfunction are not fully understood.

Purpose of the Study:

• To investigate the impact of aging on proteasome activity and assembly in the mouse brain.
• To explore the role of proteasome functionality versus composition in age-related decline.
• To evaluate the therapeutic potential of enhancing proteasome function for cognitive enhancement in aging.

Main Methods:

• Assessed 20S and 26S proteasome activities and assembly in aged mouse brains, including the hippocampus.
• Utilized genetic manipulation to overexpress the proteasome subunit PSMB5 in neurons.
• Administered acute proteasome activator treatment to aged mice.

Main Results:

• A significant reduction in 20S and 26S proteasome activities was observed in aged mice, primarily due to reduced proteasome functionality.
• While 20S proteasome assembly declined with age, 26S proteasome assembly increased, yet its activity decreased.
• Overexpression of PSMB5 and proteasome activator treatment ameliorated age-related spatial learning and memory deficits.

Conclusions:

• Age-related cognitive decline is largely driven by decreased proteasome functionality, not altered composition.
• Augmenting proteasome function offers a promising therapeutic avenue to counteract cognitive impairments associated with aging.
• Targeting proteasome activity may represent a novel strategy for mitigating age-related memory loss.